| pubmed-article:18029460 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18029460 | lifeskim:mentions | umls-concept:C0001430 | lld:lifeskim |
| pubmed-article:18029460 | lifeskim:mentions | umls-concept:C0205322 | lld:lifeskim |
| pubmed-article:18029460 | lifeskim:mentions | umls-concept:C0033727 | lld:lifeskim |
| pubmed-article:18029460 | lifeskim:mentions | umls-concept:C1273404 | lld:lifeskim |
| pubmed-article:18029460 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:18029460 | pubmed:dateCreated | 2008-2-8 | lld:pubmed |
| pubmed-article:18029460 | pubmed:abstractText | Radiation therapy is a potentially curative treatment for corticotroph adenomas refractory to surgery. Protons have an advantage over photons (x-rays) by depositing energy at the target with no exit dose, providing a lower dose to adjacent normal tissues. Until recently, proton stereotactic radiotherapy (PSR) was available at only two U.S. centers; use will increase as proton facilities are under development. | lld:pubmed |
| pubmed-article:18029460 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18029460 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18029460 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:18029460 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18029460 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18029460 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18029460 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:18029460 | pubmed:issn | 0021-972X | lld:pubmed |
| pubmed-article:18029460 | pubmed:author | pubmed-author:AncukiewiczMa... | lld:pubmed |
| pubmed-article:18029460 | pubmed:author | pubmed-author:LoefflerJay... | lld:pubmed |
| pubmed-article:18029460 | pubmed:author | pubmed-author:BillerBeverly... | lld:pubmed |
| pubmed-article:18029460 | pubmed:author | pubmed-author:SwearingenBro... | lld:pubmed |
| pubmed-article:18029460 | pubmed:author | pubmed-author:KlibanskiAnne... | lld:pubmed |
| pubmed-article:18029460 | pubmed:author | pubmed-author:CoenJohn JJJ | lld:pubmed |
| pubmed-article:18029460 | pubmed:author | pubmed-author:ChapmanPaulP | lld:pubmed |
| pubmed-article:18029460 | pubmed:author | pubmed-author:YockTorunn... | lld:pubmed |
| pubmed-article:18029460 | pubmed:author | pubmed-author:PetitJoshua... | lld:pubmed |
| pubmed-article:18029460 | pubmed:author | pubmed-author:BussiereMarcM | lld:pubmed |
| pubmed-article:18029460 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18029460 | pubmed:volume | 93 | lld:pubmed |
| pubmed-article:18029460 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18029460 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18029460 | pubmed:pagination | 393-9 | lld:pubmed |
| pubmed-article:18029460 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:meshHeading | pubmed-meshheading:18029460... | lld:pubmed |
| pubmed-article:18029460 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18029460 | pubmed:articleTitle | Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. | lld:pubmed |
| pubmed-article:18029460 | pubmed:affiliation | Department of Radiation Oncology, Massachusetts General Hospital, 100 Blossom Street, Cox 347, Boston, Massachusetts 02114, USA. | lld:pubmed |
| pubmed-article:18029460 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18029460 | lld:pubmed |
